Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BUROSUMAB-TWZA Cause Therapeutic response shortened? 23 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Therapeutic response shortened have been filed in association with BUROSUMAB-TWZA. This represents 0.5% of all adverse event reports for BUROSUMAB-TWZA.

23
Reports of Therapeutic response shortened with BUROSUMAB-TWZA
0.5%
of all BUROSUMAB-TWZA reports
0
Deaths
1
Hospitalizations

How Dangerous Is Therapeutic response shortened From BUROSUMAB-TWZA?

Of the 23 reports, 1 (4.3%) required hospitalization.

Is Therapeutic response shortened Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BUROSUMAB-TWZA. However, 23 reports have been filed with the FAERS database.

What Other Side Effects Does BUROSUMAB-TWZA Cause?

Inappropriate schedule of product administration (579) Blood phosphorus decreased (509) Product dose omission issue (475) Arthralgia (285) Pain (279) Pain in extremity (272) Headache (226) Restless legs syndrome (217) Incorrect dose administered (215) Injection site pain (205)

What Other Drugs Cause Therapeutic response shortened?

DUPILUMAB (6,720) ADALIMUMAB (2,597) INFLIXIMAB-DYYB (1,837) INFLIXIMAB (1,231) SECUKINUMAB (1,097) RISANKIZUMAB-RZAA (1,089) CARBIDOPA\LEVODOPA (1,027) ONABOTULINUMTOXINA (907) ERENUMAB-AOOE (805) CERTOLIZUMAB PEGOL (687)

Which BUROSUMAB-TWZA Alternatives Have Lower Therapeutic response shortened Risk?

BUROSUMAB-TWZA vs BUSPIRONE BUROSUMAB-TWZA vs BUSULFAN BUROSUMAB-TWZA vs BUSULFEX BUROSUMAB-TWZA vs BUTALBITAL BUROSUMAB-TWZA vs BUTENAFINE

Related Pages

BUROSUMAB-TWZA Full Profile All Therapeutic response shortened Reports All Drugs Causing Therapeutic response shortened BUROSUMAB-TWZA Demographics